Naringin has been shown to ameliorate AD neurocyte structural lesions through mechanisms such as reducing Aβ and Tau protein phosphorylation (Meng et al., 2021), modulating the glutamate system (Wang et al., 2013), and chelating excess metals (Prakash et al., 2013). Here, MAPT is linked to Alzheimer disease.